1. Prescription drug monitoring programs: Assessing the association between 'best practices' and opioid use in Medicare
- Author
-
G. Caleb Alexander, Francis B. Palumbo, Eberechukwu Onukwugha, Beth Ann Griffin, Donna Harrington, Linda Simoni-Wastila, and Patience Moyo
- Subjects
Male ,Drug Utilization ,Pain ,Medicare ,Gee ,03 medical and health sciences ,0302 clinical medicine ,Humans ,Medicine ,030212 general & internal medicine ,Prescription Drug Monitoring Program ,Medical prescription ,Association (psychology) ,Aged ,Aged, 80 and over ,business.industry ,030503 health policy & services ,Health Policy ,Opioid use ,Prescribing Patterns ,Opioid-Related Disorders ,United States ,Analgesics, Opioid ,Opioid ,Prescription opioid ,Practice Guidelines as Topic ,Prescription Drug Monitoring Programs ,Female ,0305 other medical science ,business ,medicine.drug ,Demography - Abstract
OBJECTIVE: To estimate the impact of implementing prescription drug monitoring program (PDMP) best practices on prescription opioid use. DATA SOURCES: 2007–2012 Medicare claims for noncancer pain patients, and PDMP attributes from the Prescription Drug Abuse Policy System. STUDY DESIGN: We derived PDMP composite scores using the number of best practices adopted by states (range: 0‐14), classifying states as either no PDMP, low strength (0
- Published
- 2019
- Full Text
- View/download PDF